Finch Therapeutics Group, Inc. (FNCH)
USD 12.74
(-0.08%)
USD 12.74
(-0.08%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -46.59 USD | 34.86% |
| 2022 | -71.52 USD | -102.78% |
| 2021 | -35.27 USD | -44.61% |
| 2020 | -24.39 USD | -92.35% |
| 2019 | -12.68 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -3.01 USD | -24.9% |
| 2024 Q1 | -2.41 USD | -27.51% |
| 2023 Q3 | -1.51 USD | 65.13% |
| 2023 FY | - USD | 34.86% |
| 2023 Q4 | -1.89 USD | -25.17% |
| 2023 Q2 | -4.33 USD | 89.15% |
| 2023 Q1 | -39.89 USD | -142.05% |
| 2022 Q2 | -14.36 USD | 7.35% |
| 2022 Q1 | -15.50 USD | -28.74% |
| 2022 FY | - USD | -102.78% |
| 2022 Q4 | -16.48 USD | 34.63% |
| 2022 Q3 | -25.21 USD | -75.56% |
| 2021 FY | - USD | -44.61% |
| 2021 Q4 | -12.04 USD | -91.41% |
| 2021 Q3 | -6.29 USD | 34.48% |
| 2021 Q1 | -29.89 USD | 36.2% |
| 2021 Q2 | -9.60 USD | 67.88% |
| 2020 FY | - USD | -92.35% |
| 2020 Q4 | -46.85 USD | -27.83% |
| 2020 Q3 | -36.65 USD | -19.34% |
| 2020 Q2 | -30.71 USD | -1.92% |
| 2020 Q1 | -30.13 USD | 0.0% |
| 2019 FY | - USD | 0.0% |